P38MAPK, ERK and PI3K signaling pathways are involved in C5a-Primed neutrophils for ANCA-Mediated activation

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Hao, Jian ^a,b   Meng, Li Qiang ^a   Xu, Peng Cheng ^a   Chen, Min ^a   Zhao, Ming Hui ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b INNER MONGOLIA MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 6 O; COMPLEMENT COMPONENT C5A; DIHYDRORHODAMINE 123; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NEUTROPHIL CYTOPLASMIC ANTIBODY; PHOSPHATIDYLINOSITOL 3 KINASE; RHODAMINE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; UNCLASSIFIED DRUG; ENZYME INHIBITOR; MYELOBLASTIN; PEROXIDASE; PROTEIN KINASE B;

ANTIGEN EXPRESSION; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; DEGRANULATION; DRUG ACTIVITY; ENZYME ACTIVATION; ENZYME INHIBITION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; NEUTROPHIL; NORMAL HUMAN; OXIDATION; PROTEIN PHOSPHORYLATION; RESPIRATORY BURST; SIGNAL TRANSDUCTION; WESTERN BLOTTING; CELL MEMBRANE; DRUG EFFECT; ENZYMOLOGY; IMMUNOLOGY; LEUKOCYTE ACTIVATION; METABOLISM; PHOSPHORYLATION; PROTEIN TRANSPORT;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; CELL DEGRANULATION; CELL MEMBRANE; COMPLEMENT C5A; ENZYME INHIBITORS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; MYELOBLASTIN; NEUTROPHIL ACTIVATION; NEUTROPHILS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PEROXIDASE; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-AKT; RESPIRATORY BURST; SIGNAL TRANSDUCTION;

EID: 84861711297     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038317     Document Type: Article

References (37)

1. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, et al. (1994) Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37: 187-92.
2. Falk RJ, Terrell RS, Charles LA, Jennette JC, (1990) Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci U S A 87: 4115-9.
3. Charles LA, Caldas ML, Falk RJ, Terrell RS, Jennette JC, (1991) Antibodies against granule proteins activate neutrophils in vitro. J Leukoc Biol 50: 539-46.
4. Keogan MT, Esnault VL, Green AJ, Lockwood CM, Brown DL, (1992) Activation of normal neutrophils by anti-neutrophil cytoplasm antibodies. Clin Exp Immunol 90: 228-34.
5. Mulder AH, Heeringa P, Brouwer E, Limburg PC, Kallenberg CG, (1994) Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA): a Fc gamma RII-dependent process. Clin Exp Immunol 98: 270-8.
6. Hewins P, Morgan MD, Holden N, Neil D, Williams JM, et al. (2006) IL-18 is upregulated in the kidney and primes neutrophil responsiveness in ANCA-associated vasculitis. Kidney Int 69: 605-15.
7. Xiao H, Heeringa P, Hu P, Liu Z, Zhao M, et al. (2002) Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest 110: 955-63.
8. Xiao H, Heeringa P, Liu Z, Huugen D, Hu P, et al. (2005) The role of neutrophils in the induction of glomerulonephritis by anti-myeloperoxidase antibodies. Am J Pathol 167: 39-45.
9. Xiao H, Schreiber A, Heeringa P, Falk RJ, Jennette JC, (2007) Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies. Am J Pathol 170: 52-64.
10. Huugen D, van Esch A, Xiao H, Peutz-Kootstra CJ, Buurman WA, et al. (2007) Inhibition of complement factor C5 protects against anti-myeloperoxidase antibody-mediated glomerulonephritis in mice. Kidney Int 71: 646-54.
11. Xing GQ, Chen M, Liu G, Heeringa P, Zhang JJ, et al. (2009) Complement activation is involved in renal damage in human antineutrophil cytoplasmic autoantibody associated pauci-immune vasculitis. J Clin Immunol 29: 282-91.
12. Schreiber A, Xiao H, Jennette JC, Schneider W, Luft FC, et al. (2009) C5a receptor mediates neutrophil activation and ANCA-induced glomerulonephritis. J Am Soc Nephrol 20: 289-98.
13. Cobb MH, Goldsmith EJ, (1995) How MAP kinases are regulated. J Biol Chem 270: 14843-6.
14. Paul A, Wilson S, Belham CM, Robinson CJ, Scott PH, et al. (1997) Stress-activated protein kinases: activation, regulation and function. Cell Signal 9: 403-10.
15. Kettritz R, Schreiber A, Luft FC, Haller H, (2001) Role of mitogen-activated protein kinases in activation of human neutrophils by antineutrophil cytoplasmic antibodies. J Am Soc Nephrol 12: 37-46.
16. Van der Veen BS, Chen M, Muller R, van Timmeren MM, Petersen AH, et al. (2011) Effects of p38 mitogen-activated protein kinase inhibition on anti-neutrophil cytoplasmic autoantibody pathogenicity in vitro and in vivo. Ann Rheum Dis 70: 356-65.
17. Schreiber A, Rolle S, Peripelittchenko L, Rademann J, Schneider W, et al. (2010) Phosphoinositol 3-kinase-gamma mediates antineutrophil cytoplasmic autoantibody-induced glomerulonephritis. Kidney Int 77: 118-28.
18. Wrann CD, Tabriz NA, Barkhausen T, Klos A, van Griensven M, et al. (2007) The phosphatidylinositol 3-kinase signaling pathway exerts protective effects during sepsis by controlling C5a-mediated activation of innate immune functions. J Immunol 178: 5940-8.
19. Choi M, Rolle S, Rane M, Haller H, Luft FC, et al. (2003) Extracellular signal-regulated kinase inhibition by statins inhibits neutrophil activation by ANCA. Kidney Int 63: 96-106.
20. Manthey CL, Wang SW, Kinney SD, Yao Z, (1998) SB202190, a selective inhibitor of p38 mitogen-activated protein kinase, is a powerful regulator of LPS-induced mRNAs in monocytes. J Leukoc Biol 64: 409-17.
21. Runden E, Seglen PO, Haug FM, Ottersen OP, Wieloch T, et al. (1998) Regional selective neuronal degeneration after protein phosphatase inhibition in hippocampal slice cultures: evidence for a MAP kinase-dependent mechanism. J Neurosci 18: 7296-305.
22. Veeranna, Amin ND, Ahn NG, Jaffe H, Winters CA, et al. (1998) Mitogen-activated protein kinases (Erk1,2) phosphorylate Lys-Ser-Pro (KSP) repeats in neurofilament proteins NF-H and NF-M. J Neurosci 18: 4008-21.
23. Xing J, Kornhauser JM, Xia Z, Thiele EA, Greenberg ME, et al. (1998) Nerve growth factor activates extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways to stimulate CREB serine 133 phosphorylation. Mol Cell Biol 18: 1946-55.
24. Kauskot A, Adam F, Mazharian A, Ajzenberg N, Berrou E, et al. (2007) Involvement of the mitogen-activated protein kinase c-Jun NH2-terminal kinase 1 in thrombus formation. J Biol Chem 282: 31990-9.
25. Vlahos CJ, Matter WF, Hui KY, Brown RF, (1994) A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem 269: 5241-8.
26. Schaeffer V, Cuschieri J, Garcia I, Knoll M, Billgren J, et al. (2007) The priming effect of C5a on monocytes is predominantly mediated by the p38 MAPK pathway. Shock 27: 623-30.
27. Lonnerdal B, Iyer S, (1995) Lactoferrin: molecular structure and biological function. Annu Rev Nutr 15: 93-110.
28. Baker EN, Baker HM, (2005) Molecular structure, binding properties and dynamics of lactoferrin. Cell Mol Life Sci 62: 2531-9.
29. Talor MV, Stone JH, Stebbing J, Barin J, Rose NR, et al. (2007) Antibodies to selected minor target antigens in patients with anti-neutrophil cytoplasmic antibodies (ANCA). Clin Exp Immunol 150: 42-8.
30. Rodriguez-Franco DA, Vazquez-Moreno L, Ramos-Clamont MG, (2005) Antimicrobial mechanisms and potential clinical application of lactoferrin. Rev Latinoam Microbiol 47: 102-11.
31. Franssen CF, Huitema MG, Muller KA, Oost-Kort WW, Limburg PC, et al. (1999) In vitro neutrophil activation by antibodies to proteinase 3 and myeloperoxidase from patients with crescentic glomerulonephritis. J Am Soc Nephrol 10: 1506-15.
32. Guo RF, Ward PA, (2005) Role of C5a in inflammatory responses. Annu Rev Immunol 23: 821-52.
33. Hess C, Sadallah S, Schifferli JA, (2000) Induction of neutrophil responsiveness to myeloperoxidase antibodies by their exposure to supernatant of degranulated autologous neutrophils. Blood 96: 2822-7.
34. Porges AJ, Redecha PB, Kimberly WT, Csernok E, Gross WL, et al. (1994) Anti-neutrophil cytoplasmic antibodies engage and activate human neutrophils via Fc gamma RIIa. J Immunol 153: 1271-80.
35. Reumaux D, Vossebeld PJ, Roos D, Verhoeven AJ, (1995) Effect of tumor necrosis factor-induced integrin activation on Fc gamma receptor II-mediated signal transduction: relevance for activation of neutrophils by anti-proteinase 3 or anti-myeloperoxidase antibodies. Blood 86: 3189-95.
36. Witko-Sarsat V, Cramer EM, Hieblot C, Guichard J, Nusbaum P, et al. (1999) Presence of proteinase 3 in secretory vesicles: evidence of a novel, highly mobilizable intracellular pool distinct from azurophil granules. Blood 94: 2487-96.
37. Kettritz R, Choi M, Butt W, Rane M, Rolle S, et al. (2002) Phosphatidylinositol 3-kinase controls antineutrophil cytoplasmic antibodies-induced respiratory burst in human neutrophils. J Am Soc Nephrol 13: 1740-9.